ATH 0.00% 0.3¢ alterity therapeutics limited

Ann: New Publication Demonstrates ATH434 is Neuroprotective, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,085 Posts.
    lightbulb Created with Sketch. 532
    the delay is the rarity of the disease and the need for more information to develop the right endpoints for trials. best to be as informed as possible to accurately pinpoint all the effects of MSA on patients so that we can see how 434 affects function in all of these areas and thus measure the benefit to patients overall.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.